Lenograstim as Support for ACE Chemotherapy of Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenograstim as Support for ACE Chemotherapy of Small-Cell Lung Cancer

Published:2000-08 Issue:4 Volume:23 Page:393-400
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology: Cancer Clinical Trials
language:en
Short-container-title:American Journal of Clinical Oncology: Cancer Clinical Trials

Author:

Gatzemeier U.,Kleisbauer J. P.,Drings P.,Kaukel E.,Samaras N.,Melo M. J.,Cardenal F.,Robinet G.,Snijder R. J.,von Pawel J.,Palisses R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference15 articles.

1. Granulocyte and granulocyte-macrophage colony-stimulating factors

2. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.

3. Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer;Head and Neck Tumors (HNT);2021-11-12

2. Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis;Scientific Reports;2019-10-25

3. Immunotherapy for Invasive Mold Disease in Transplant Patients: Dendritic Cell Immunotherapy, Interferon Gamma, Recombinant Myeloid Growth Factors, and Healthy Donor Granulocyte Transfusions;Principles and Practice of Transplant Infectious Diseases;2019

4. Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2017-12

5. Predicting neutropenia risk in patients with cancer using electronic data;Journal of the American Medical Informatics Association;2016-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3